Attached files

file filename
EX-8.1 - OPINION OF VINSON & ELKINS L.L.P., RELATING TO TAX MATTERS. - Calumet Specialty Products Partners, L.P.d350226dex81.htm
EX-5.1 - OPINION OF VINSON & ELKINS L.L.P. - Calumet Specialty Products Partners, L.P.d350226dex51.htm
EX-1.1 - UNDERWRITING AGREEMENT, DATED MAY 8, 2012 - Calumet Specialty Products Partners, L.P.d350226dex11.htm
EX-99.2 - PRESS RELEASE, DATED MAY 8, 2012, ANNOUNCING THE PRICING OF THE COMMON UNITS - Calumet Specialty Products Partners, L.P.d350226dex992.htm
EX-99.1 - PRESS RELEASE, DATED MAY 7, 2012, ANNOUNCING THE COMMON UNITS OFFERING. - Calumet Specialty Products Partners, L.P.d350226dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 8, 2012

 

 

CALUMET SPECIALTY PRODUCTS PARTNERS, L.P.

(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE   000-51734   37-1516132

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

2780 Waterfront Pkwy E. Drive

Suite 200

Indianapolis, Indiana46214

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code (317) 328-5660

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01 Entry into a Material Definitive Agreement.

Common Units Underwriting Agreement

On May 8, 2012, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet GP, LLC (the “General Partner”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Goldman, Sachs & Co. and J.P. Morgan Securities LLC, as joint book-running managers and representatives of the several underwriters named therein (collectively, the “Underwriters”), which provides for the issuance and sale by the Partnership, and purchase by the Underwriters, of 6,000,000 common units representing limited partner interests in the Partnership (the “Common Units”) relating to a public offering of such Common Units at $25.50 per Common Unit. The Underwriters were also granted a 30-day option to purchase up to 900,000 additional Common Units. The material terms of the offering of the Common Units are described in the prospectus supplement, dated May 8, 2012 (the “Prospectus Supplement”), as filed by the Partnership with the Securities and Exchange Commission (the “Commission”). The offer and sale of the Common Units are registered with the Commission pursuant to a Registration Statement on Form S-3 (File No. 333-170390), and the closing with respect to the public offering of such Common Units is expected to occur on May 11, 2012, subject to customary closing conditions.

The Partnership intends to use the net proceeds from the Common Units offering, including a proportionate capital contribution from the General Partner, to repay borrowings outstanding under its revolving credit facility and for general partnership purposes, including working capital, capital expenditures and acquisitions.

Certain of the Underwriters and their respective affiliates have provided, and may in the future provide, various financial advisory, sales and trading, commercial and investment banking and other financial and non-financial activities and services to the Partnership and its affiliates, for which they received or will receive customary fees and expenses. Affiliates of certain of the Underwriters are lenders under the Partnership’s revolving credit facility and, in such capacity, will receive a portion of the net proceeds from the Common Units offering resulting from the repayment of borrowings outstanding under the Partnership’s revolving credit facility. The Partnership has also entered into, in the ordinary course of business, various derivative financial instrument transactions related to its crude oil and natural gas purchases and sales of finished fuel products with affiliates of certain of the underwriters.

The Underwriting Agreement contains customary representations, warranties and agreements of the Partnership and certain affiliates, and customary conditions to closing, indemnification rights, obligations of the parties and termination provisions.

The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On May 7, 2012, the Partnership issued a press release announcing the launch of the Common Units offering described in Item 1.01 of this Current Report on Form 8-K. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

1


On May 8, 2012, the Partnership issued a press release announcing the pricing of the Common Units described in Item 1.01 of this Current Report on Form 8-K. A copy of this press release is furnished as Exhibit 99.2 to this Current Report on Form 8-K.

The information contained in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

    

Exhibit
Number

  

Description

   1.1    Underwriting Agreement, dated May 8, 2012, by and among the Partnership, the General Partner and the Underwriters named therein, relating to the Common Units.
   5.1    Opinion of Vinson & Elkins L.L.P.
   8.1    Opinion of Vinson & Elkins L.L.P., relating to tax matters.
  23.1    Consent of Vinson & Elkins L.L.P. (included in Exhibit 5.1 hereto).
  23.2    Consent of Vinson & Elkins L.L.P. (included in Exhibit 8.1 hereto).
  99.1    Press Release, dated May 7, 2012, announcing the Common Units offering.
  99.2    Press Release, dated May 8, 2012, announcing the pricing of the Common Units offering.

 

2


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CALUMET SPECIALITY PRODUCTS PARTNERS, L.P.
  By:   CALUMET GP, LLC,
    its General Partner
Date: May 9, 2012   By:  

/s/ R. Patrick Murray, II

  Name:   R. Patrick Murray, II
  Title:   Vice President, Chief Financial Officer and Secretary

 

3


Exhibit Index

 

Exhibit
Number

  

Description

 1.1    Underwriting Agreement, dated May 8, 2012, by and among the Partnership, the General Partner and the Underwriters named therein, relating to the Common Units.
 5.1    Opinion of Vinson & Elkins L.L.P.
 8.1    Opinion of Vinson & Elkins L.L.P., relating to tax matters.
23.1    Consent of Vinson & Elkins L.L.P. (included in Exhibit 5.1 hereto).
23.2    Consent of Vinson & Elkins L.L.P. (included in Exhibit 8.1 hereto).
99.1    Press Release, dated May 7, 2012, announcing the Common Units offering.
99.2    Press Release, dated May 8, 2012, announcing the pricing of the Common Units offering.

 

4